PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.35%
Revenue growth under 50% of 4997.T's 22.86%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-3.36%
Negative gross profit growth while 4997.T is at 33.42%. Joel Greenblatt would examine cost competitiveness or demand decline.
-38.35%
Negative EBIT growth while 4997.T is at 114.75%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-18.20%
Negative operating income growth while 4997.T is at 114.75%. Joel Greenblatt would press for urgent turnaround measures.
-55.37%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-55.32%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-55.32%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-93.11%
Negative 10Y revenue/share CAGR while 4997.T stands at 85.56%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-26.07%
Negative 5Y CAGR while 4997.T stands at 68.58%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-7.29%
Negative 3Y CAGR while 4997.T stands at 25.72%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
92.77%
Positive 10Y CAGR while 4997.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-2690.48%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-152.21%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
52.20%
5Y equity/share CAGR above 1.5x 4997.T's 34.69%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.88%
3Y equity/share CAGR above 1.5x 4997.T's 3.03%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.62%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
12.04%
We show growth while 4997.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.21%
Positive asset growth while 4997.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-3.64%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
9.70%
We have some new debt while 4997.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Our R&D shrinks while 4997.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.92%
SG&A growth of 2.92% while 4997.T is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.